What are the differences between tetanus toxoid (TT) and tetanus‑diphtheria (Td) vaccines, including when each should be administered?

Tetanus Toxoid vs Td: Key Differences and When to Use Each

Td (tetanus-diphtheria) vaccine should be used instead of tetanus toxoid (TT) alone for all routine immunizations in persons aged ≥7 years, as Td protects against both tetanus and diphtheria while TT only protects against tetanus. 1

Vaccine Composition

Tetanus Toxoid (TT):

• Contains only tetanus toxoid antigen
• Provides protection against tetanus only
• No longer recommended for routine use in the United States

Td (Tetanus-Diphtheria):

• Contains 2 Lf tetanus toxoid + 2 Lf diphtheria toxoid 2
• Provides protection against both tetanus AND diphtheria
• Standard formulation for adults and children ≥7 years

When to Use Td

Routine Booster Immunization:

• Every 10 years throughout life starting at age 11-12 years 1
• Primary series (if never vaccinated): 3 doses total—first dose, second dose ≥4 weeks later, third dose 6-12 months after second 3

Wound Management:

• For clean, minor wounds: Give Td if ≥10 years since last tetanus-containing vaccine 3
• For contaminated/severe wounds: Give Td if ≥5 years since last tetanus-containing vaccine 3
• Important caveat: If patient has never received Tdap (tetanus-diphtheria-pertussis), use Tdap instead of Td for wound management 1

Pregnancy:

• If a booster is needed outside the Tdap window (27-36 weeks), Td can be used 3

Why Td Over TT Alone

The Advisory Committee on Immunization Practices (ACIP) has recommended Td over TT since 1966 because:

• Both protect against tetanus equally
• Only Td provides diphtheria protection
• Diphtheria remains a threat, particularly for travelers to endemic areas 4

Safety Profile: While Td causes slightly more local reactions (pain at injection site) compared to TT alone, the overall adverse event rate remains low—40 reports per million doses for Td vs 27 per million for TT 5. This small increase in local reactogenicity is clinically acceptable given the added protection against diphtheria.

Common Pitfalls to Avoid

1. Don't use TT when Td is indicated: Despite ACIP recommendations, approximately 2.5 million doses of TT were still distributed annually in the 1990s, likely due to misconceptions about Td safety 5

2. Don't confuse Td with Tdap:

   • Td = tetanus + diphtheria (for routine boosters)
   • Tdap = tetanus + diphtheria + pertussis (one-time dose for adults who never received it, plus pregnancy dosing)

3. Timing in wound management: Tetanus toxoid/Td provides protection for future injuries, not the current one—there's no urgency for immediate administration in the acute setting 4. However, follow the 5-year or 10-year guidelines based on wound type.

4. Arthus reactions: Patients with history of Arthus-type hypersensitivity after prior tetanus-containing vaccine should not receive Td more frequently than every 10 years, even for wound management 3

Algorithm for Decision-Making

For any patient ≥7 years needing tetanus immunization:

1. Has patient ever received Tdap?

   • No → Use Tdap (not Td) for first dose
   • Yes → Proceed to step 2

2. Is patient pregnant (27-36 weeks)?

   • Yes → Use Tdap (regardless of prior Tdap history) 1
   • No → Proceed to step 3

3. Is this for routine booster (no wound)?

   • Yes, ≥10 years since last dose → Use Td 1
   • No → Proceed to step 4

4. Is this for wound management?

   • Clean wound + ≥10 years since last dose → Use Td 3
   • Contaminated/severe wound + ≥5 years since last dose → Use Td 3

Bottom line: Never use tetanus toxoid (TT) alone when Td is available—the added diphtheria protection comes at minimal additional risk and provides crucial coverage against a preventable disease. 1, 3